Tod Loofbourrow, a technology executive and entrepreneur, is cofounder and president of iRobot Healthcare, a business unit of iRobot Corporation (NASDAQ: IRBT). The company is devoted to developing health care applications that achieve the mission of “adding a million years of independent living to our customers and their families.”
Mr. Loofbourrow most recently founded and served as chairman and CEO of Authoria, a $38 million software-as-a-service leader in the health/benefits information and talent management space, serving over 4 million users and delivering over a billion page views a year to customers. Authoria helped define the talent management space with Gartner and emerged as a top player in the field, leading to its sale in 2008.
Mr. Loofbourrow has been actively involved in the health space for 20 years. He recently collaborated with David Cutler, David Blumenthal, Erik Brynjolfsson, and others in developing a $19 billion part of the American Recovery and Reinvestment Act of 2009 associated with providing doctors and hospitals with incentives to deploy and meaningfully use electronic medical records to better collaborate across the medical system, and to better aggregate data on what works and what doesn’t for improving patients’ outcomes.
Previously, Mr. Loofbourrow was founder, managing director, and CEO of Foundation Technologies, Inc., a strategic consulting firm specializing in content, rule, and knowledge-based systems for Fortune 2000 CIOs. Notable customer successes include the first-ever Managed Second Surgical Opinion system for managed care, built for Aetna and Medical Intelligence—and later sold to McKesson.
Mr. Loofbourrow was educated at Harvard and Oxford universities. He taught graduate courses on Internet commerce and artificial intelligence at Harvard University for seven years and has lectured at Stanford, the MIT Sloan School of Management, Harvard Business School, Babson College, and others. He is the author or chapter contributor to six books, the first of which was a 20,000-copy trade bestseller on computer science and robotics, written at the age of 16.